AVIR 8-K: Material agreement
Atea Pharmaceuticals
Filed with the SEC on · accession 0001193125-26-452659
AVIR filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Atea Pharmaceuticals entered into a $200 million senior secured term loan facility with Hercules Capital, with $65 million drawn at closing and additional tranches tied to clinical and commercial milestones for its BEM/RZR program.
Key details
✦ Ask GOAX AI about this filing — what it means for AVIR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AVIR?
Click hereFrequently asked questions
What did AVIR file with the SEC on Nov 9, 2026?
AVIR filed a 8-K (Material agreement). Atea Pharmaceuticals entered into a $200 million senior secured term loan facility with Hercules Capital, with $65 million drawn at closing and additional tranches tied to clinical and commercial milestones for its BEM/RZR program.
What does a material agreement mean for AVIR stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other AVIR SEC filings
Get alerts when AVIR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days